ADMA Biologics, Inc.ADMANASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+22.3%
5Y CAGR+28.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+22.3%/yr
vs +29.5%/yr prior
5Y CAGR
+28.8%/yr
Recent deceleration
Acceleration
-7.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $217.41M | +5.1% |
| 2024 | $206.90M | +22.2% |
| 2023 | $169.27M | +42.5% |
| 2022 | $118.81M | +48.9% |
| 2021 | $79.77M | +30.1% |
| 2020 | $61.29M | +55.2% |
| 2019 | $39.50M | -6.4% |
| 2018 | $42.19M | +44.7% |
| 2017 | $29.16M | +358.5% |
| 2016 | $6.36M | - |